Frontiers in Oncology (Jan 2024)

Vorasidenib in IDH1/2-mutant low-grade glioma: the grey zone of patient’s selection

  • Lidia Gatto,
  • Vincenzo Di Nunno,
  • Alicia Tosoni,
  • Stefania Bartolini,
  • Lucia Ranieri,
  • Enrico Franceschi

DOI
https://doi.org/10.3389/fonc.2023.1339266
Journal volume & issue
Vol. 13

Abstract

Read online

No abstracts available.

Keywords